Cortical gets a chance to shine on global stage
Published 16-AUG-2016 15:30 P.M.
|
2 minute read
Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.
In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.
The below articles were written under our previous business model. We have kept these articles online here for your reference.
Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.
Click Here to View Latest Articles
BPH Energy (ASX:BPH) investee company Cortical Dynamics has the technology and business plan to go global.
That’s the call from the Australian Technologies Competition (ATC), which has selected Cortical and its next-gen Brain Function Monitor as a semi-finalist in the competition.
The competition, which has generated $250 million in investment for finalists over the past five years, are an opportunity for innovative small to medium tech companies to showcase their wares to some of the biggest players around.
Judges for the competition are drawn from companies such as Deloitte, Bird&Bird, and FB Rice.
The ATC also draws support from: the Australian Department of Industry, Innovation and Science; Hong Kong Trade & Development Council and; UK Trade and Investment.
Selection in the semi-finals of the competition is somewhat of a boon for Cortical, as the competition this year is not only focusing on technology but the ability for a company to globally scale their business.
“The Semi Finalists will have unmatched profiling opportunities with industry that will help them get to market and realise their potential in Australia and globally,” competition organiser John O’Brien said in a statement.
Cortical will be showcasing its BAR technology, which purportedly improves on the currently used EEG technologies by incorporating the latest advances in understanding of how the brain’s rhythmic electrical activity is produced.
The BAR’s underlying algorithm produces EEG indexes which are directly related to the physiological state of the patient’s brain.
It estimates that the global brain monitoring market was worth $1.08 billion in 2012 and could grow at an annual compound growth rate of 8.6% to reach $1.63 billion by next year.
How much of this addressable market BAR is able to capture is unknown, thus all factors relating to the company, not this fact alone, should be taken into account if considering BAR for your investment portfolio.
MEC Resources holds an 8.3% stake in BPH
General Information Only
S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.